<p>(<b>A</b>) MethA transfectant secreting sCD155 (sCD155-MethA) or control protein (Mock-MethA) were inoculated into peritoneal cavity and then ascites was collected. sCD155 levels in ascites of mice that had been inoculated with these transfectantss were measured by ELISA. (<b>B</b>) BALB/c mice were inoculated subcutaneously with sCD155-MethA transfectant. Tumor size and sCD155 levels in serum were measured and the correlation coefficient was calculated.</p
a) Kaplan-Meier survival analysis. b) Change in tumor growth over time as determined by caliper meas...
<p>The C16:1/C16:0, C18:1/C18:0 (A) and C18:0/C16:0 (B) ratios were calculated, based on data obtain...
<p><b>a</b> shows on the left side a control mouse (width of mouse 20 mm) not injected with ID8 cell...
<p>BALB/c mice were irradiated with 3 Gy, and Meth-A cells were then subcutaneously inoculated into ...
<p>(<b>A</b>) Murine CXCL13 levels in the serum of control mice (n = 13) and in the serum of mice wi...
<p>On day 0, mice were injected with PBS (control treatment), AAV-scFv6H4, or AAV-scFv7F9. Serum scF...
<p>(A, B) WT (<i>n</i> = 18 and 16, respectively) or CD155-deficient (KO; <i>n</i> = 19 and 20, resp...
<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immu...
<p>A: Course of Smad7 expression observed by immune-staining in the liver from <i>E. multilocularis<...
<p>a&b) α<sub>2</sub>M was purified from mice bearing solid tumors, tumors as ascites or from naïve ...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Female Balb/c nu/nu mice, 8 weeks of age, were being injected subcutaneously in both flanks with ...
<p>(A) Measurement of body weight in nude mice once per week. (B) Measurement of tumor volume in nud...
<p>A: Course of pSmad2/3 expression observed by immune-staining in the liver from <i>E. multilocular...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
a) Kaplan-Meier survival analysis. b) Change in tumor growth over time as determined by caliper meas...
<p>The C16:1/C16:0, C18:1/C18:0 (A) and C18:0/C16:0 (B) ratios were calculated, based on data obtain...
<p><b>a</b> shows on the left side a control mouse (width of mouse 20 mm) not injected with ID8 cell...
<p>BALB/c mice were irradiated with 3 Gy, and Meth-A cells were then subcutaneously inoculated into ...
<p>(<b>A</b>) Murine CXCL13 levels in the serum of control mice (n = 13) and in the serum of mice wi...
<p>On day 0, mice were injected with PBS (control treatment), AAV-scFv6H4, or AAV-scFv7F9. Serum scF...
<p>(A, B) WT (<i>n</i> = 18 and 16, respectively) or CD155-deficient (KO; <i>n</i> = 19 and 20, resp...
<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immu...
<p>A: Course of Smad7 expression observed by immune-staining in the liver from <i>E. multilocularis<...
<p>a&b) α<sub>2</sub>M was purified from mice bearing solid tumors, tumors as ascites or from naïve ...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Female Balb/c nu/nu mice, 8 weeks of age, were being injected subcutaneously in both flanks with ...
<p>(A) Measurement of body weight in nude mice once per week. (B) Measurement of tumor volume in nud...
<p>A: Course of pSmad2/3 expression observed by immune-staining in the liver from <i>E. multilocular...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
a) Kaplan-Meier survival analysis. b) Change in tumor growth over time as determined by caliper meas...
<p>The C16:1/C16:0, C18:1/C18:0 (A) and C18:0/C16:0 (B) ratios were calculated, based on data obtain...
<p><b>a</b> shows on the left side a control mouse (width of mouse 20 mm) not injected with ID8 cell...